Literature DB >> 15805136

E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.

Thomas A Russo1, Bruce A Davidson, Stacy A Genagon, Natalie M Warholic, Ulrike Macdonald, Patrick D Pawlicki, Janet M Beanan, Ruth Olson, Bruce A Holm, Paul R Knight.   

Abstract

Enteric gram-negative bacilli, such as Escherichia coli are the most common cause of nosocomial pneumonia. In this study a wild-type extraintestinal pathogenic strain of E. coli (ExPEC)(CP9) and isogenic derivatives deficient in hemolysin (Hly) and cytotoxic necrotizing factor (CNF) were assessed in vitro and in a rat model of gram-negative pneumonia to test the hypothesis that these virulence factors induce neutrophil apoptosis and/or necrosis/lysis. As ascertained by in vitro caspase-3/7 and LDH activities and neutrophil morphology, Hly mediated neutrophil apoptosis at lower E. coli titers (1 x 10(5-6) cfu) and necrosis/lysis at higher titers (> or =1 x 10(7) cfu). Data suggest that CNF promotes apoptosis but not necrosis or lysis. We also demonstrate that annexin V/7-amino-actinomycin D staining was an unreliable assessment of apoptosis using live E. coli. The use of caspase-3/7 and LDH activities and neutrophil morphology supported the notion that necrosis, not apoptosis, was the primary mechanism by which neutrophils were affected in our in vivo gram-negative pneumonia model using live E. coli. In addition, in vivo studies demonstrated that Hly mediates lung injury. Neutrophil necrosis was not observed when animals were challenged with purified lipopolysaccharide, demonstrating the importance of using live bacteria. These findings establish that Hly contributes to ExPEC virulence by mediating neutrophil toxicity, with necrosis/lysis being the dominant effect of Hly on neutrophils in vivo and by lung injury. Whether Hly-mediated lung injury is due to neutrophil necrosis, a direct effect of Hly, or both is unclear.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805136     DOI: 10.1152/ajplung.00482.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  30 in total

1.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

2.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 4.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

5.  Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.

Authors:  Yarery C Smith; Kerian K Grande; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

7.  Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

Authors:  May Khalili; Laura N Mutton; Bora Gurel; Jessica L Hicks; Angelo M De Marzo; Charles J Bieberich
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

8.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 9.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.